Matches in Wikidata for { <http://www.wikidata.org/entity/Q89927532> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q89927532 description "article scientifique publié en 2020" @default.
- Q89927532 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89927532 description "scientific article published on 27 February 2020" @default.
- Q89927532 description "wetenschappelijk artikel" @default.
- Q89927532 description "наукова стаття, опублікована 27 лютого 2020" @default.
- Q89927532 description "գիտական հոդված հրատարակված 2020 թվականի փետրվարի 27-ին" @default.
- Q89927532 name "Induction therapy with rituximab for lupus nephritis due to prolidase deficiency" @default.
- Q89927532 name "Induction therapy with rituximab for lupus nephritis due to prolidase deficiency" @default.
- Q89927532 type Item @default.
- Q89927532 label "Induction therapy with rituximab for lupus nephritis due to prolidase deficiency" @default.
- Q89927532 label "Induction therapy with rituximab for lupus nephritis due to prolidase deficiency" @default.
- Q89927532 prefLabel "Induction therapy with rituximab for lupus nephritis due to prolidase deficiency" @default.
- Q89927532 prefLabel "Induction therapy with rituximab for lupus nephritis due to prolidase deficiency" @default.
- Q89927532 P1433 Q89927532-20A01908-1F81-4DE0-84FA-2D8449D9EB91 @default.
- Q89927532 P1476 Q89927532-BB05B677-CDE0-4D95-90E6-4D6A3AA1D0BE @default.
- Q89927532 P2093 Q89927532-0BF153E5-03DC-4F0F-8B84-C219CFD4DAF4 @default.
- Q89927532 P2093 Q89927532-201335D1-1D3F-4617-B58E-220761CD9729 @default.
- Q89927532 P2093 Q89927532-382F932E-94E8-49F6-9688-656982F74C48 @default.
- Q89927532 P2093 Q89927532-476B9948-A49E-4C40-8732-5164A927B8E0 @default.
- Q89927532 P2093 Q89927532-4807C03F-C509-46CA-90C3-11D3A0FA7FFD @default.
- Q89927532 P2093 Q89927532-75987243-04A8-4652-9E45-F76AA7366933 @default.
- Q89927532 P2093 Q89927532-8C3E8CC6-DEFF-4517-96ED-0AFD1160EBBC @default.
- Q89927532 P2093 Q89927532-ACA5E4F1-B490-4465-B80C-9A2E0EF55CEA @default.
- Q89927532 P2093 Q89927532-E338F296-9E08-4F33-ACBD-6A32E4EE3CA0 @default.
- Q89927532 P31 Q89927532-49D818C1-9CD7-4E91-BE26-803E4F8CB472 @default.
- Q89927532 P356 Q89927532-94624C1B-1E13-4EA3-8E76-A199A8202220 @default.
- Q89927532 P577 Q89927532-3BEE0BF2-525A-437E-931D-647C1228B755 @default.
- Q89927532 P698 Q89927532-5BEB6AD8-0091-404C-9A68-735ECF8461FE @default.
- Q89927532 P921 Q89927532-06E26E13-20D5-4A41-9D1A-25E2D30AC8B8 @default.
- Q89927532 P921 Q89927532-9C7BCE19-5E81-451D-9729-B55E714D836E @default.
- Q89927532 P921 Q89927532-C174383B-B6EC-47F1-8691-8D0761E5AA84 @default.
- Q89927532 P356 KEAA051 @default.
- Q89927532 P698 32107546 @default.
- Q89927532 P1433 Q7320492 @default.
- Q89927532 P1476 "Induction therapy with rituximab for lupus nephritis due to prolidase deficiency" @default.
- Q89927532 P2093 "Eisuke Suganuma" @default.
- Q89927532 P2093 "Kimitoshi Nakamura" @default.
- Q89927532 P2093 "Kohsuke Imai" @default.
- Q89927532 P2093 "Mihoko Furuichi" @default.
- Q89927532 P2093 "Satoshi Sato" @default.
- Q89927532 P2093 "Shuichiro Fujinaga" @default.
- Q89927532 P2093 "Takuma Ohnishi" @default.
- Q89927532 P2093 "Yoji Uejima" @default.
- Q89927532 P2093 "Yutaka Kawano" @default.
- Q89927532 P31 Q13442814 @default.
- Q89927532 P356 "10.1093/RHEUMATOLOGY/KEAA051" @default.
- Q89927532 P577 "2020-02-27T00:00:00Z" @default.
- Q89927532 P698 "32107546" @default.
- Q89927532 P921 Q1621830 @default.
- Q89927532 P921 Q412323 @default.
- Q89927532 P921 Q7249599 @default.